Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
Theresa Klemm, Gregor Ebert, Dale J. Calleja, et al.
The EMBO Journal (2020) Vol. 39, Iss. 18
Open Access | Times Cited: 428

Showing 1-25 of 428 citing articles:

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
Wioletta Rut, Zongyang Lv, Mikołaj Żmudziński, et al.
Science Advances (2020) Vol. 6, Iss. 42
Open Access | Times Cited: 425
Structural biology of SARS-CoV-2 and implications for therapeutic development
Haitao Yang, Zihe Rao
Nature Reviews Microbiology (2021) Vol. 19, Iss. 11, pp. 685-700
Open Access | Times Cited: 402
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya, Shweta Kumari, Bharati Pandey, et al.
Journal of Molecular Biology (2020) Vol. 433, Iss. 2, pp. 166725-166725
Open Access | Times Cited: 311
Crystal structure of SARS-CoV-2 papain-like protease
Xiaopan Gao, Bo Qin, Pu Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 237-245
Open Access | Times Cited: 295
Ubiquitination in the regulation of inflammatory cell death and cancer
Peter E. Cockram, Matthias Kist, Sumit Prakash, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 591-605
Open Access | Times Cited: 290
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
Ziyang Fu, Bin Huang, Jinle Tang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 270
ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
Guanqun Liu, Jung‐Hyun Lee, Zachary M. Parker, et al.
Nature Microbiology (2021) Vol. 6, Iss. 4, pp. 467-478
Open Access | Times Cited: 262
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
Mehdi Moustaqil, Emma Ollivier, Hsin-Ping Chiu, et al.
Emerging Microbes & Infections (2020) Vol. 10, Iss. 1, pp. 178-195
Open Access | Times Cited: 233
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
An expanded lexicon for the ubiquitin code
Ivan Ðikić, Brenda A. Schulman
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 4, pp. 273-287
Open Access | Times Cited: 213
Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
Rita M. Meganck, Ralph S. Baric
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 401-410
Open Access | Times Cited: 194
Innate immune sensing of coronavirus and viral evasion strategies
Yusuke Kasuga, Baohui Zhu, Kyoung‐Jin Jang, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 723-736
Open Access | Times Cited: 181
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Zhengnan Shen, Kiira Ratia, Laura Cooper, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2940-2955
Open Access | Times Cited: 173
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 173
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
Chunlong Ma, M. Sacco, Zilei Xia, et al.
ACS Central Science (2021) Vol. 7, Iss. 7, pp. 1245-1260
Open Access | Times Cited: 158
Innate immune evasion strategies of SARS-CoV-2
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 157
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 147
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Yao Zhao, Xiaoyu Du, Yinkai Duan, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 877-888
Open Access | Times Cited: 134
Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor
Jin‐Gu Lee, Weiliang Huang, Hangnoh Lee, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 117
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Haozhou Tan, Yanmei Hu, Prakash D. Jadhav, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7561-7580
Open Access | Times Cited: 115
The Ubiquitin–Proteasome System in Immune Cells
Gonca Çetin, Sandro Klafack, Maja Studencka‐Turski, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 60-60
Open Access | Times Cited: 110
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
Zongyang Lv, Kristin E. Cano, Lijia Jia, et al.
Frontiers in Chemistry (2022) Vol. 9
Open Access | Times Cited: 75
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2
Brian Sanders, Suman Pokhrel, Audrey Labbé, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top